FOR IMMEDIATE RELEASE:
For More Information Please Contact:
Dr. Ben Drillings, Director
American Israeli Medical Association
(888) 991-1212 or email@example.com
Billionaire Biomedical CEO Alfred Mann to Headline
American Israeli Medical Association BioMedTech Conference
in L.A. November 15, 2011
October 26, 2011(Los Angeles, CA) – The American Israeli Medical Association (AIMA) today announced it will hold its first, annual BioMedTech Conference at Los Angeles’ Skirball Cultural Center on Tuesday, November 15, 2011 from 6 p.m. – 10 p.m. According to Dr. Ben Drillings, director of AIMA, the keynote speaker for the event will be world-renowned aerospace and biomedical entrepreneur and philanthropist Alfred E. Mann, chairman and CEO of MannKind Corporation. Mr. Mann has founded 17 companies over six decades including: Spectrolab, Heliotek, MiniMed and Advanced Bionics and developed key health products such as pacemakers, cochlear implants and insulin pumps. The topic of Mann’s presentation will be “Creating Medical Device Enterprise.”
The AIMA conference will be a major event featuring leading Israeli dignitaries and key scientists and executives from Israel’s thriving research and biomedical companies. Joining Mann are a bevy of prestigious speakers: David Seigel, Consul General of Israel in Los Angeles; Jacob Offenberger M.D., President, AIMA; Dr. Zeev Feldman, Chairman, IMA-WF; and Dr. Ben Drillings, Director & Founder, AIMA. Over 300 attendees are expected to attend to hear about Israel’s leading BioMedTech companies. Among those registered are investors, venture capitalists, professional firms, executives, medical doctors, academicians and entrepreneurs.
Dr. Ben Drillings, director and founder of AIMA, notes, “Israel is a world-leading center for biomedical technology and the #1 innovator of medical devices. In Israel, biomedical technology is a booming industry leading the world in innovation. Israel has produced ten Nobel Prize winners with four Israeli academics winning in the area of chemistry. The conference will introduce the Israeli BioMedTech industry to the California business community.”
According to the 2011 Life Science Industry Catalogue published by Israel’s Ministry of Industry, Trade and Labor, Israel rates #1 in the world for medical device patents per capita, #4 for BioPharma patents, and #4 in Global Scientific activity for the number of scientific publications per citizen. As of 2010, there were over 1,100 BioMedTech companies operating in Israel. Of those, 41% have formed during the last five years and 34% have already begun to generate revenue.
“I am asking everyone to come and see the innovation that is coming from Israel,” says Dr. Drillings, “because these innovations will help make humankind healthier and change the way healthcare is provided.”
The Skirball Cultural Center is located at 2701 Sepulveda Boulevard in Los Angeles.
To register for the event, visit: www.aima4u.com. Email at: firstname.lastname@example.org or call: (888) 991-1212. For press information, please contact Pat Kramer, Writer For Hire, at (818) 353-5699 or email@example.com.